Intermittent acute porphyria: on the purpose of a case.

Porfiria aguda intermitente: a propósito de un caso

Main Article Content

Ana Carolina Parada Cabal
Sandra Carolina Giraldo Lora
María Isabel Rodriguez Castro
Luis Fernando Daza
Lida Milena Araujo Cabrera
Iván Mauricio Llanos Arango
Daniel Ibagón Rengifo
Liliana Mejía Zapata
José Fernando Gómez Urrego
Abstract

Porphyrias are inherited metabolic diseases due to partial or total enzyme deficiency in the heme synthesis pathway, which leads to the accumulation of porphyrins and toxic precursors in the tissues. The clinical presentation is heterogeneous depending on the affected enzyme, with increased excretion of porphyrins and/or precursors, which allows diagnosis. In the case of acute intermittent porphyria, a deficit of porphobilinogen deaminase is established. Treatment is based on adequate metabolic intake and supply of human Hemin.  The case of a patient of 17 years of age is described, with recurrent gastrointestinal symptoms, severe hydroelectrolytic imbalance during her hospitalization, with a change in the color of urine due to sun exposure and increased porphyrins in urine, for which it is established metabolic support and later directed treatment with human hemin due to the high suspicion, obtaining several days later a report of elevated levels of Delta Amino Levulinic Acid. It is concluded that despite being a diagnosis of exclusion, it should be considered as differential, especially in the event of recurrence of symptoms, with no common etiology identified, and the rapid initiation of general measures and directed management with human hemin is necessary.

Keywords

Downloads

Download data is not yet available.

Article Details

Author Biographies (SEE)

Ana Carolina Parada Cabal, Universidad Libre. Cali, Colombia.

Residente de tercer año de pediatría.

Sandra Carolina Giraldo Lora, Universidad Libre. Cali, Colombia

Pediatra

María Isabel Rodriguez Castro, Universidad Libre. Cali, Colombia.

Pediatra

Luis Fernando Daza, Fundación Clínica Infantil Club Noel

Médico general.

Lida Milena Araujo Cabrera, Fundación Clínica Infantil Club Noel

Hematóloga y oncóloga pediatra.

Iván Mauricio Llanos Arango, Universidad Libre. Cali, Colombia.

Gastroenterólogo pediatra.

Daniel Ibagón Rengifo, Universidad Libre. Cali, Colombia.

Pediatra con énfasis en nutrición pediátrica.

Liliana Mejía Zapata, Fundación Clínica Infantil Club Noel

Endocrinóloga pediatra.

José Fernando Gómez Urrego, Universidad Libre. Cali, Colombia.

Pediatra.

References

Stein PE, Badminton MN, Rees DC. Update review of the acute porphyrias. Br J Haematol [Internet]. 2017 Feb;176(4):527–38. Disponible en: http://doi.wiley.com/10.1111/bjh.14459

Kauppinen R. Porphyrias. Lancet. [Internet]. 2005;365(9455):241–52. Disponible en: doi: 10.1016/S0140-6736(05)17744-7.

Siegesmund M, Van Tuyll Van Serooskerken AM, Poblete-Gutiérrez P, Frank J. The acute hepatic porphyrias: Current status and future challenges. Best Pract Res Clin Gastroenterol [Internet]. 2010;24(5):593–605. Disponible en: http://dx.doi.org/10.1016/j.bpg.2010.08.010

Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute intermittent porphyria: Current perspectives and case presentation. Ther Clin Risk Manag. [Internet]. 2019;15:1443–51. Disponible en: doi: 10.2147/TCRM.S180161.

Cardenas JL, Guerrero C. Acute intermittent porphyria: general aspects with focus on pain. Curr Med Res Opin [Internet]. 2018;34(7):1309–15. Disponible en: https://doi.org/10.1080/03007995.2018.1435521

Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. [Internet]. 2015;8:201–14. Disponible en: https://doi.org/10.2147/TACG.S48605.

Ramanujam VMS, Anderson KE. Porphyria diagnostics-part 1: A brief overview of the porphyrias. Curr Protoc Hum Genet. [Internet]. 2015 Jul;86:17.20.1-17.20.26. Disponible en: 10.1002/0471142905.hg1720s86

Yang J, Chen Q, Yang H, Hua B, Zhu T, Zhao Y, et al. Clinical and Laboratory Features of Acute Porphyria: A Study of 36 Subjects in a Chinese Tertiary Referral Center. Biomed Res Int. [Internet]. 2016;2016:ID3927635 1-5. Disponible en: https://doi.org/10.1155/2016/3927635

Ventura P, Cappellini MD, Biolcati G, Guida CC, Rocchi E, Graziadei G, et al. A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias. Eur J Intern Med. [Internet]. 2014;25(6):497–505. Disponible en: https://doi.org/10.1016/j.ejim.2014.03.011

Gonzalez-Aseguinolaza G. Givosiran — Running RNA Interference to Fight Porphyria Attacks. N Engl J Med. [Internet]. 2020;382(24):2366–7. Disponible en: https://doi.org/10.1056/NEJMe2010986

Torregrosa L, Ayala JC, Cervera S, Villa C. La porfiria aguda intermitente y el cirujano: un reto diagnóstico: reporte de un caso y revisión de la literatura. Rev Colomb Cirugía. [Internet]. 2011;26(2):131–7. Disponible en: https://www.revistacirugia.org/index.php/cirugia/article/view/171

Bustos J, Vargas L, Quintero R. Acute intermittent porphyria: A case report. Biomedica. [Internet]. 2020;40(1):14–9. Disponible en: https://doi.org/10.7705/biomedica.4767

Latorre G MA. Porfiria intermitente aguda. J Bras Med. [Internet]. 2000;78(6):90–2. Disponible en: http://actamedicacolombiana.com/anexo/articulos/05-1988-03.pdf

Neeleman RA, Wensink D, Wagenmakers MAEM, Mijnhout GS, Friesema ECH, Langendonk JG. Diagnostic and therapeutic strategies for porphyrias. Neth J Med. [Internet]. 2020;78(4):149–60. Disponible en: https://www.njmonline.nl/getpdf.php?id=2219

OJS System - Metabiblioteca |